WELWYN GARDEN CITY, England and BOSTON, April 16, 2013 /PRNewswire/ --
Heptares Therapeutics, the leading GPCR drug discovery company, notes that it will be presenting at the following scientific conferences and biotech industry events over the coming weeks.
8th Annual Drug Discovery Chemistry (San Diego, CA, USA, April 16-18)
Dr Rob Cooke , Heptares' Head of Biomolecular Structure, will give a presentation entitled "Utilizing Structural Insights in GPCR Drug Discovery" as part of the GPCR-Based Drug Design stream (2:40pm, 17 April). Dr Cooke will also be hosting an evening workshop on "Practical Aspects of Structure-based Drug Discovery with GPCRs" at the meeting.
2013 BIO International Convention (22-25 April, Chicago, IL, USA)
Mr Dan Grau (President) will present an overview of the Company during the BioBusiness Forum, which takes place from 8:00am-11:00am on 24 April. Dr Barry Kenny (Chief Business Officer) and Dr Cath Hutchings (Antibody Discovery & Strategic Partnering) will also be present at the event.
4th GPCR Colloquium at The American Society for Pharmacology and Experimental Therapeutics (ASPET) meeting (Boston, MA, USA, 24-25 April)
Dr Fiona Marshall , Heptares' Chief Scientific Officer, will present a talk entitled "X-ray Structures for the Predictive Generation of GPCR Drugs" (2:15pm, 25 April).
|SOURCE Heptares Therapeutics|
Copyright©2012 PR Newswire.
All rights reserved